UA125728U - METHOD OF ATOPIC DERMATITIS TREATMENT - Google Patents

METHOD OF ATOPIC DERMATITIS TREATMENT

Info

Publication number
UA125728U
UA125728U UAU201711928U UAU201711928U UA125728U UA 125728 U UA125728 U UA 125728U UA U201711928 U UAU201711928 U UA U201711928U UA U201711928 U UAU201711928 U UA U201711928U UA 125728 U UA125728 U UA 125728U
Authority
UA
Ukraine
Prior art keywords
atopic dermatitis
dermatitis treatment
immunomodulatory drug
treatment
leukon
Prior art date
Application number
UAU201711928U
Other languages
Ukrainian (uk)
Inventor
Анатолій Миколайович Гольцев
Ганна Костянтинівна Коваль
Максим Вадимович Останков
Олена Дмитрівна Луценко
Микола Олександрович Бондарович
Людмила Василівна Останкова
Катерина Євгеніївна Ямпольська
Юлія Олександрівна Гаєвська
Original Assignee
Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України filed Critical Інститут Проблем Кріобіології І Кріомедицини Національної Академії Наук України
Priority to UAU201711928U priority Critical patent/UA125728U/en
Publication of UA125728U publication Critical patent/UA125728U/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Спосіб лікування атопічного дерматиту включає використання імуномодулюючого препарату. При цьому як імуномодулюючий препарат використовують кріоконсервований лейкоконцентрат кордової крові людини.A method of treating atopic dermatitis involves the use of an immunomodulatory drug. In this case, as a immunomodulatory drug used cryopreserved leukon concentrate human cord blood.

UAU201711928U 2017-12-05 2017-12-05 METHOD OF ATOPIC DERMATITIS TREATMENT UA125728U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201711928U UA125728U (en) 2017-12-05 2017-12-05 METHOD OF ATOPIC DERMATITIS TREATMENT

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201711928U UA125728U (en) 2017-12-05 2017-12-05 METHOD OF ATOPIC DERMATITIS TREATMENT

Publications (1)

Publication Number Publication Date
UA125728U true UA125728U (en) 2018-05-25

Family

ID=62171451

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201711928U UA125728U (en) 2017-12-05 2017-12-05 METHOD OF ATOPIC DERMATITIS TREATMENT

Country Status (1)

Country Link
UA (1) UA125728U (en)

Similar Documents

Publication Publication Date Title
EP3749255A4 (en) Methods, apparatus and devices to treat heart valves
MX2022008868A (en) Treatment of cancer with tg02.
EP3505091A4 (en) Medical device and treatment method
CY1123366T1 (en) 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES
BR112017026061A2 (en) compound, use of a compound, and method of treating a viral infection
AU2018337076A1 (en) Method of treatment
PH12019500725A1 (en) Methods of treating acute kidney injury
AU2015267099A8 (en) Use of eribulin in the treatment of cancer
EP3423124A4 (en) Device, system and method to customize chest drainage therapy
MX2017013047A (en) Treatment of pain.
EP3570983A4 (en) Hair treatment system, treatments and apparatus
EP3508148A4 (en) Medical device and treatment method
JO3541B1 (en) Medical treatments based on anamorelin
EP3520724A4 (en) Medical device and treatment method
EP3505110A4 (en) Medical device and treatment method
EP3427678A4 (en) Medical device and treatment method
EA202090260A1 (en) MEANS AND METHODS FOR HUMAN AAV GENOTHERAPY
EP3549582A3 (en) Novel capsazepine analogs for the treatment of cancer and other proliferative diseases
EP3508149A4 (en) Medical device and treatment method
WO2016102930A3 (en) Medical device for treating a vein
UA125728U (en) METHOD OF ATOPIC DERMATITIS TREATMENT
EP3272715A4 (en) Water treatment device, water treatment method, sterile water production device, and sterile water production method
MX2019014475A (en) Formulations of lixivaptan for the treatment of polycystic disease.
EP3522100A4 (en) Dementia patient care burden degree determination device, dementia patient care burden degree determination method, dementia patient care burden degree determination program, dementia treatment effect determination device, dementia treatment effect determination method, and dementia treatment effect determination program
EP4074818A3 (en) Tissue organoids